ML15131A170
| ML15131A170 | |
| Person / Time | |
|---|---|
| Site: | SHINE Medical Technologies |
| Issue date: | 05/01/2015 |
| From: | Bynum R Shine Medical Technologies |
| To: | Office of Nuclear Reactor Regulation |
| Lynch S | |
| References | |
| SHINE, SHINE.SUBMISSION.14, SHN.PSAR.P, SHN.PSAR.P.6 | |
| Download: ML15131A170 (6) | |
Text
Chapter 16 - Other License Considerations Table of Contents SHINE Medical Technologies 16-i Rev. 0 CHAPTER 16 OTHER LICENSE CONSIDERATIONS Table of Contents Section Title Page 16.1 PRIOR USE OF FACILITY COMPONENTS...................................................16-1 16.2 MEDICAL USE OF THE FACILITY.................................................................16-2
Chapter 16 - Other License Considerations List of Tables SHINE Medical Technologies 16-ii Rev. 0 List of Tables Number Title None
Chapter 16 - Other License Considerations List of Figures SHINE Medical Technologies 16-iii Rev. 0 List of Figures Number Title None
Chapter 16 - Other License Considerations Acronyms and Abbreviations SHINE Medical Technologies 16-iv Rev. 0 Acronyms and Abbreviations Acronym/Abbreviation Definition SHINE SHINE Medical Technologies, Inc.
Chapter 16 - Other License Considerations Prior Use of Facility Components SHINE Medical Technologies 16-1 Rev. 0 CHAPTER 16 OTHER LICENSE CONSIDERATIONS 16.1 PRIOR USE OF FACILITY COMPONENTS The SHINE Medical Technologies, Inc. (SHINE) facility utilizes new and appropriately-qualified components and systems to conduct production operations. Discussions regarding used components and systems are not applicable to the SHINE facility.
Chapter 16 - Other License Considerations Medical Use of the Facility SHINE Medical Technologies 16-2 Rev. 0 16.2 MEDICAL USE OF THE FACILITY The SHINE facility does not contain equipment or facilities associated with direct medical administration of radioisotopes or other radiation-based therapies. Therefore, discussions involving medical use of the SHINE facility are not applicable.